+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Postpartum Depression Market Report 2025 - Product Thumbnail Image

Postpartum Depression Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Stem Cell Therapy Market Report 2025 - Product Thumbnail Image

Stem Cell Therapy Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
From
Post-Traumatic Stress Disorder Therapeutics Market Report 2025 - Product Thumbnail Image

Post-Traumatic Stress Disorder Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
Cardiovascular Drugs - Global Strategic Business Report - Product Thumbnail Image

Cardiovascular Drugs - Global Strategic Business Report

  • Report
  • May 2025
  • 413 Pages
  • Global
From
Fungal Keratitis Treatment Market 2024-2028 - Product Thumbnail Image

Fungal Keratitis Treatment Market 2024-2028

  • Report
  • September 2024
  • 170 Pages
  • Global
From
Antibody Drug Conjugates Market Report 2025-2035 - Product Thumbnail Image

Antibody Drug Conjugates Market Report 2025-2035

  • Report
  • December 2024
  • 342 Pages
  • Global
From
From
Inhaled Antibiotics Market Report 2025 - Product Thumbnail Image

Inhaled Antibiotics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Nanomedicine Market Report and Forecast 2023-2031 - Product Thumbnail Image

Nanomedicine Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
5' Nucleotidase - Pipeline Review, H1 2020 - Product Thumbnail Image

5' Nucleotidase - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 109 Pages
  • Global
From
Loading Indicator